United States Human Insulin Market Report 2018

Name: United States Human Insulin Market Report 2018
Brand: QYResearch
SKU: U62360D7B5DQEN
Price: 3800 USD
Availability: InStock

March 2018 | 104 pages | ID: U62360D7B5DQEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Human Insulin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Human Insulin in these regions, from 2013 to 2025 (forecast).

United States Human Insulin market competition by top manufacturers/players, with Human Insulin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Sanofi (France)
Eli Lilly and Company (U.S.)
Biocon Ltd. (India)
Julphar (U.A.E.)
Ypsomed AG (Switzerland)
Becton
Dickinson and Company (U.S.)
Wockhardt Ltd. (India)
B. Braun Meselgen AG (Switzerland)
Biodel Inc(U.S.)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Short Acting Human Insulin
Intermediate Acting Human Insulin
Premixed Human Insulin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Insulin Dependent Diabetes Mellitus
Non-Insulin Dependent Diabetes Mellitus

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Human Insulin Market Report 2018

1 HUMAN INSULIN OVERVIEW

1.1 Product Overview and Scope of Human Insulin
1.2 Classification of Human Insulin by Product Category
  1.2.1 United States Human Insulin Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Human Insulin Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Short Acting Human Insulin
  1.2.4 Intermediate Acting Human Insulin
  1.2.5 Premixed Human Insulin
1.3 United States Human Insulin Market by Application/End Users
  1.3.1 United States Human Insulin Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Insulin Dependent Diabetes Mellitus
  1.3.3 Non-Insulin Dependent Diabetes Mellitus
1.4 United States Human Insulin Market by Region
  1.4.1 United States Human Insulin Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Human Insulin Status and Prospect (2013-2025)
  1.4.3 Southwest Human Insulin Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Human Insulin Status and Prospect (2013-2025)
  1.4.5 New England Human Insulin Status and Prospect (2013-2025)
  1.4.6 The South Human Insulin Status and Prospect (2013-2025)
  1.4.7 The Midwest Human Insulin Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Human Insulin (2013-2025)
  1.5.1 United States Human Insulin Sales and Growth Rate (2013-2025)
  1.5.2 United States Human Insulin Revenue and Growth Rate (2013-2025)

2 UNITED STATES HUMAN INSULIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Insulin Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Human Insulin Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Human Insulin Average Price by Players/Suppliers (2013-2018)
2.4 United States Human Insulin Market Competitive Situation and Trends
  2.4.1 United States Human Insulin Market Concentration Rate
  2.4.2 United States Human Insulin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Insulin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN INSULIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Human Insulin Sales and Market Share by Region (2013-2018)
3.2 United States Human Insulin Revenue and Market Share by Region (2013-2018)
3.3 United States Human Insulin Price by Region (2013-2018)

4 UNITED STATES HUMAN INSULIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Human Insulin Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Human Insulin Revenue and Market Share by Type (2013-2018)
4.3 United States Human Insulin Price by Type (2013-2018)
4.4 United States Human Insulin Sales Growth Rate by Type (2013-2018)

5 UNITED STATES HUMAN INSULIN SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Human Insulin Sales and Market Share by Application (2013-2018)
5.2 United States Human Insulin Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN INSULIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi (France)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Insulin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi (France) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly and Company (U.S.)
  6.2.2 Human Insulin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly and Company (U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Biocon Ltd. (India)
  6.3.2 Human Insulin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Biocon Ltd. (India) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Julphar (U.A.E.)
  6.4.2 Human Insulin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Julphar (U.A.E.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Ypsomed AG (Switzerland)
  6.5.2 Human Insulin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Ypsomed AG (Switzerland) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Becton
  6.6.2 Human Insulin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Becton Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Dickinson and Company (U.S.)
  6.7.2 Human Insulin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Dickinson and Company (U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Wockhardt Ltd. (India)
  6.8.2 Human Insulin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Wockhardt Ltd. (India) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 B. Braun Meselgen AG (Switzerland)
  6.9.2 Human Insulin Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 B. Braun Meselgen AG (Switzerland) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Biodel Inc(U.S.)
  6.10.2 Human Insulin Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Biodel Inc(U.S.) Human Insulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 HUMAN INSULIN MANUFACTURING COST ANALYSIS

7.1 Human Insulin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Insulin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Insulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Insulin Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN INSULIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Human Insulin Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Human Insulin Sales Volume Forecast by Type (2018-2025)
11.3 United States Human Insulin Sales Volume Forecast by Application (2018-2025)
11.4 United States Human Insulin Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Insulin
Figure United States Human Insulin Market Size (Kg) by Type (2013-2025)
Figure United States Human Insulin Sales Volume Market Share by Type (Product Category) in 2017
Figure Short Acting Human Insulin Product Picture
Figure Intermediate Acting Human Insulin Product Picture
Figure Premixed Human Insulin Product Picture
Figure United States Human Insulin Market Size (Kg) by Application (2013-2025)
Figure United States Sales Market Share of Human Insulin by Application in 2017
Figure Insulin Dependent Diabetes Mellitus Examples
Table Key Downstream Customer in Insulin Dependent Diabetes Mellitus
Figure Non-Insulin Dependent Diabetes Mellitus Examples
Table Key Downstream Customer in Non-Insulin Dependent Diabetes Mellitus
Figure United States Human Insulin Market Size (Million USD) by Region (2013-2025)
Figure The West Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Human Insulin Sales (Kg) and Growth Rate (2013-2025)
Figure United States Human Insulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Human Insulin Market Major Players Product Sales Volume (Kg) (2013-2018)
Table United States Human Insulin Sales (Kg) of Key Players/Suppliers (2013-2018)
Table United States Human Insulin Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Human Insulin Sales Share by Players/Suppliers
Figure 2017 United States Human Insulin Sales Share by Players/Suppliers
Figure United States Human Insulin Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Human Insulin Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Human Insulin Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Human Insulin Revenue Share by Players/Suppliers
Figure 2017 United States Human Insulin Revenue Share by Players/Suppliers
Table United States Market Human Insulin Average Price (USD/G) of Key Players/Suppliers (2013-2018)
Figure United States Market Human Insulin Average Price (USD/G) of Key Players/Suppliers in 2017
Figure United States Human Insulin Market Share of Top 3 Players/Suppliers
Figure United States Human Insulin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Insulin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Insulin Product Category
Table United States Human Insulin Sales (Kg) by Region (2013-2018)
Table United States Human Insulin Sales Share by Region (2013-2018)
Figure United States Human Insulin Sales Share by Region (2013-2018)
Figure United States Human Insulin Sales Market Share by Region in 2017
Table United States Human Insulin Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Human Insulin Revenue Share by Region (2013-2018)
Figure United States Human Insulin Revenue Market Share by Region (2013-2018)
Figure United States Human Insulin Revenue Market Share by Region in 2017
Table United States Human Insulin Price (USD/G) by Region (2013-2018)
Table United States Human Insulin Sales (Kg) by Type (2013-2018)
Table United States Human Insulin Sales Share by Type (2013-2018)
Figure United States Human Insulin Sales Share by Type (2013-2018)
Figure United States Human Insulin Sales Market Share by Type in 2017
Table United States Human Insulin Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Human Insulin Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Human Insulin by Type (2013-2018)
Figure Revenue Market Share of Human Insulin by Type in 2017
Table United States Human Insulin Price (USD/G) by Types (2013-2018)
Figure United States Human Insulin Sales Growth Rate by Type (2013-2018)
Table United States Human Insulin Sales (Kg) by Application (2013-2018)
Table United States Human Insulin Sales Market Share by Application (2013-2018)
Figure United States Human Insulin Sales Market Share by Application (2013-2018)
Figure United States Human Insulin Sales Market Share by Application in 2017
Table United States Human Insulin Sales Growth Rate by Application (2013-2018)
Figure United States Human Insulin Sales Growth Rate by Application (2013-2018)
Table Sanofi (France) Basic Information List
Table Sanofi (France) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Sanofi (France) Human Insulin Sales Growth Rate (2013-2018)
Figure Sanofi (France) Human Insulin Sales Market Share in United States (2013-2018)
Figure Sanofi (France) Human Insulin Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company (U.S.) Basic Information List
Table Eli Lilly and Company (U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Eli Lilly and Company (U.S.) Human Insulin Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company (U.S.) Human Insulin Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company (U.S.) Human Insulin Revenue Market Share in United States (2013-2018)
Table Biocon Ltd. (India) Basic Information List
Table Biocon Ltd. (India) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Biocon Ltd. (India) Human Insulin Sales Growth Rate (2013-2018)
Figure Biocon Ltd. (India) Human Insulin Sales Market Share in United States (2013-2018)
Figure Biocon Ltd. (India) Human Insulin Revenue Market Share in United States (2013-2018)
Table Julphar (U.A.E.) Basic Information List
Table Julphar (U.A.E.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Julphar (U.A.E.) Human Insulin Sales Growth Rate (2013-2018)
Figure Julphar (U.A.E.) Human Insulin Sales Market Share in United States (2013-2018)
Figure Julphar (U.A.E.) Human Insulin Revenue Market Share in United States (2013-2018)
Table Ypsomed AG (Switzerland) Basic Information List
Table Ypsomed AG (Switzerland) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Ypsomed AG (Switzerland) Human Insulin Sales Growth Rate (2013-2018)
Figure Ypsomed AG (Switzerland) Human Insulin Sales Market Share in United States (2013-2018)
Figure Ypsomed AG (Switzerland) Human Insulin Revenue Market Share in United States (2013-2018)
Table Becton Basic Information List
Table Becton Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Becton Human Insulin Sales Growth Rate (2013-2018)
Figure Becton Human Insulin Sales Market Share in United States (2013-2018)
Figure Becton Human Insulin Revenue Market Share in United States (2013-2018)
Table Dickinson and Company (U.S.) Basic Information List
Table Dickinson and Company (U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Dickinson and Company (U.S.) Human Insulin Sales Growth Rate (2013-2018)
Figure Dickinson and Company (U.S.) Human Insulin Sales Market Share in United States (2013-2018)
Figure Dickinson and Company (U.S.) Human Insulin Revenue Market Share in United States (2013-2018)
Table Wockhardt Ltd. (India) Basic Information List
Table Wockhardt Ltd. (India) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Wockhardt Ltd. (India) Human Insulin Sales Growth Rate (2013-2018)
Figure Wockhardt Ltd. (India) Human Insulin Sales Market Share in United States (2013-2018)
Figure Wockhardt Ltd. (India) Human Insulin Revenue Market Share in United States (2013-2018)
Table B. Braun Meselgen AG (Switzerland) Basic Information List
Table B. Braun Meselgen AG (Switzerland) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Sales Growth Rate (2013-2018)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Sales Market Share in United States (2013-2018)
Figure B. Braun Meselgen AG (Switzerland) Human Insulin Revenue Market Share in United States (2013-2018)
Table Biodel Inc(U.S.) Basic Information List
Table Biodel Inc(U.S.) Human Insulin Sales (Kg), Revenue (Million USD), Price (USD/G) and Gross Margin (2013-2018)
Figure Biodel Inc(U.S.) Human Insulin Sales Growth Rate (2013-2018)
Figure Biodel Inc(U.S.) Human Insulin Sales Market Share in United States (2013-2018)
Figure Biodel Inc(U.S.) Human Insulin Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Insulin
Figure Manufacturing Process Analysis of Human Insulin
Figure Human Insulin Industrial Chain Analysis
Table Raw Materials Sources of Human Insulin Major Players/Suppliers in 2017
Table Major Buyers of Human Insulin
Table Distributors/Traders List
Figure United States Human Insulin Sales Volume (Kg) and Growth Rate Forecast (2018-2025)
Figure United States Human Insulin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Human Insulin Price (USD/G) Trend Forecast (2018-2025)
Table United States Human Insulin Sales Volume (Kg) Forecast by Type (2018-2025)
Figure United States Human Insulin Sales Volume (Kg) Forecast by Type (2018-2025)
Figure United States Human Insulin Sales Volume (Kg) Forecast by Type in 2025
Table United States Human Insulin Sales Volume (Kg) Forecast by Application (2018-2025)
Figure United States Human Insulin Sales Volume (Kg) Forecast by Application (2018-2025)
Figure United States Human Insulin Sales Volume (Kg) Forecast by Application in 2025
Table United States Human Insulin Sales Volume (Kg) Forecast by Region (2018-2025)
Table United States Human Insulin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Human Insulin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Human Insulin Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Human Insulin Market Report 2018

More Publications

Need Help?

Ask a Question

Market Reports